oral microdose glp 1 Noom expands its GLP-1 range with 'microdose' package GLP-1 Microdose – näky

There is little clinical evidence for these transdermal herbal patches as GLP-1 therapies

Published February 20, 2025

Patient preferences, dosing schedules, and cost are critical factors in the selection of GLP-1 receptor agonists, with healthcare professionals playing a vital role in tailoring treatments to individual needs

Association of pharmacological treatments for obesity with weight loss and adverse events

The practice of microdosing GLP-1 medications is mainly experimental and off-label

Only very small molecules can reliably pass through the skin, which is why patches work for things like nicotine, certain hormones (like estrogen), or some pain medications